Skip to main content
Loading

Amytrx Therapeutics

October 18, 2023
Franciscan C
Inflammation
Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for patients suffering from chronic inflammatory diseases. We are a group of dedicated scientific, medical, and business professionals all deeply committed to positively transforming the health and lives of patients.
Speakers
Randall Riggs - Amytrx Therapeutics